H. Ward Wolff
2013
In 2013, H. Ward Wolff earned a total compensation of $1.6M as Executive Vice President and Chief Financial Officer at Sangamo Biosciences, a 43% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $200,000 |
|---|---|
| Option Awards | $598,878 |
| Salary | $400,000 |
| Stock Awards | $424,200 |
| Total | $1,623,078 |
Wolff received $598.9K in option awards, accounting for 37% of the total pay in 2013.
Wolff also received $200K in non-equity incentive plan, $400K in salary and $424.2K in stock awards.
Rankings
In 2013, H. Ward Wolff's compensation ranked 4,622nd out of 12,286 executives tracked by ExecPay. In other words, Wolff earned more than 62.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,622 out of 12,286 | 62nd |
Division Manufacturing | 1,585 out of 4,612 | 66th |
Major group Chemicals And Allied Products | 458 out of 1,462 | 69th |
Industry group Drugs | 319 out of 1,156 | 72nd |
Industry Biological Products, Except Diagnostic Substances | 49 out of 196 | 75th |
Source: SEC filing on April 25, 2016.
Wolff's colleagues
We found four more compensation records of executives who worked with H. Ward Wolff at Sangamo Biosciences in 2013.